TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Denise A YardleyEdward R ArrowsmithBrooke R DanielJanice EakleAdam BrufskyDavid R DrosickFred KudrikLinda D BossermanMark R KeatonSharon A GobleJeffrey A BubisVictor M PriegoKelly PendergrassYvonne ManaloMartin BuryDonald S GravenorGladys I RodriguezRoger C InhornRobyn R YoungWilliam N HarwinCaryn SilverJohn D HainsworthHoward A BurrisPublished in: Breast cancer research and treatment (2017)
Clinical Trials.gov Identifier, NCT00789581.